RxDoctor Payments Data

Mary Coleman, NP

Family · Lynchburg, VANPI 1841934718

Payments from drug & device makers

$63in general payments, 2019–2025

Across 3 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$41
  • Vanda Pharmaceuticals Inc.$22

What the payments were for

  • Food & beverage$63100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie2$41
Vanda Pharmaceuticals Inc.1$22

How this compares

$63 in reported general payments places this provider in the 15th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$2,004,765
Medicare patients
353
Services billed
4,224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.15$5,033
Mupirocin110$2,587
Doxycycline Hyclate41$1,000
Gentamicin Sulfate17$989

Paid to pharmacies, not to this prescriber.

Other family in Lynchburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →